Work

Full-length dominant-negative survivin for cancer immunotherapy.

Year: 2003

Type: article

Source: PubMed

Authors: Vladimir Pisarev, Bin Yu, Raoul Salup, Simon Sherman, Dario C Altieri, Dmitry I Gabrilovich

Institution: University of Nebraska Medical Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: Control of Apoptosis in Cancer by Survivin, IMMUNOGENIC TUMOR ASSOCIATED MUCIN PEPTIDES, Molecular targeting of the survivin pathway in cancer

OpenAlex ID: W2124752540

FWCI: 3.639

Cites: 42

Cited by: 93

Related to: 10